Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Diamedica Therapeutics Inc (DMAC)

Diamedica Therapeutics Inc (DMAC)
6.25 x 1 6.28 x 7
Post-market by (Cboe BZX)
6.28 -0.10 (-1.57%) 02/11/25 [NASDAQ]
6.25 x 1 6.28 x 7
Post-market 6.28 unch (unch) 16:00 ET
Quote Overview for Tue, Feb 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.05
Day High
6.43
Open 6.43
Previous Close 6.38 6.38
Volume 26,315 26,315
Avg Vol 76,201 76,201
Stochastic %K 86.09% 86.09%
Weighted Alpha +105.95 +105.95
5-Day Change +0.30 (+5.02%) +0.30 (+5.02%)
52-Week Range 2.14 - 6.45 2.14 - 6.45
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 272,815
  • Shares Outstanding, K 42,761
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,380 K
  • EBIT $ -24 M
  • EBITDA $ -25 M
  • 60-Month Beta 1.46
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.58

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 47.08%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.16
  • Low Estimate -0.18
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -21.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.88 +28.69%
on 01/14/25
Period Open: 5.27
6.45 -2.64%
on 02/10/25
+1.01 (+19.17%)
since 01/10/25
3-Month
3.92 +60.20%
on 11/18/24
Period Open: 4.23
6.45 -2.64%
on 02/10/25
+2.05 (+48.46%)
since 11/11/24
52-Week
2.14 +193.46%
on 06/24/24
Period Open: 3.23
6.45 -2.64%
on 02/10/25
+3.05 (+94.43%)
since 02/09/24

Most Recent Stories

More News
Best Momentum Stocks to Buy for October 14th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 14th:IAMGOLD Corporation IAG: This intermediate gold producer has a Zacks Rank #1 and witnessed...

HIVE : 2.72 (-3.89%)
DMAC : 6.28 (-1.57%)
IAG : 6.38 (-1.09%)
New Strong Buy Stocks for October 14th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:HireQuest, Inc. HQI: This company that provides temporary staffing solutions has seen the Zacks Consensus Estimate for its current...

HIVE : 2.72 (-3.89%)
HQI : 12.82 (-1.00%)
CLPR : 3.96 (+0.25%)
DMAC : 6.28 (-1.57%)
IAG : 6.38 (-1.09%)
Three (3) Stocks Under $10 That Insiders Are Buying 

These small-cap names provide an opportunity that insiders are buying including deep value, growth, new technology, and AI.

DMAC : 6.28 (-1.57%)
ADT : 7.48 (+1.36%)
CMTL : 2.20 (-3.93%)
DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute ischemic stroke, announced today...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing a novel treatment for acute ischemic stroke (AIS), today announced the appointment of David...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute ischemic stroke, announced today...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls,...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment...

DMAC : 6.28 (-1.57%)
KPTI : 0.5981 (-3.98%)
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update...

DMAC : 6.28 (-1.57%)
HireQuest Announces Closing of $63.2 Million Credit Facility

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, today announced that the Company has closed a $63.2 million credit facility comprised of...

HQI : 12.82 (-1.00%)
HireQuest Set to Join Russell 3000® Index

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell...

HQI : 12.82 (-1.00%)
HireQuest Reports Financial Results for the First Quarter 2021

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, today reported financial results for the first quarter ended March 31, 2021.

HQI : 12.82 (-1.00%)
HireQuest Sets First Quarter 2021 Financial Results Conference Call for Monday, May 17, 2021 at 4:30 p.m. ET

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand and temporary staffing services, today announced that it will hold a conference call on Monday, May 17, 2021 at 4:30 p.m. Eastern time...

HQI : 12.82 (-1.00%)
HireQuest Announces Increased Quarterly Cash Dividend of $0.06 Per Share

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, today announced that its Board of Directors has declared an increased quarterly cash dividend...

HQI : 12.82 (-1.00%)
CORRECTING and REPLACING HireQuest Reports Financial Results for the Fourth Quarter and Full-Year 2020

Correcting to add the start of the quote from Rick Hermanns and remove a duplicate quote in the Fourth Quarter 2020 Financial Summary section of the text . Also removing footnote 2 from within the text....

HQI : 12.82 (-1.00%)
HireQuest Reports Financial Results for the Fourth Quarter and Full-Year 2020

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, today reported financial results for the fourth quarter and year ended December 31, 2020....

HQI : 12.82 (-1.00%)
HireQuest, Inc. Closes Acquisition of LINK Staffing

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand and temporary staffing services, today announced that its subsidiary, HQ Link Corporation, has closed the acquisition of the franchised...

HQI : 12.82 (-1.00%)
HireQuest Sets Fourth Quarter and Year End 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 4:30 p.m. ET

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand and temporary staffing services, today announced that it will hold a conference call on Thursday, March 25, 2021 at 4:30 p.m. Eastern time...

HQI : 12.82 (-1.00%)
HireQuest, Inc. Closes Acquisition of Snelling Staffing

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand and temporary staffing services, today announced that its subsidiary, HQ Snelling Corporation, has closed the acquisition of certain assets...

HQI : 12.82 (-1.00%)
HireQuest Announces Closing of $63.2 Million Credit Facility

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, today announced that the Company has closed a $63.2 million credit facility comprised of...

HQI : 12.82 (-1.00%)
HireQuest Set to Join Russell 3000® Index

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell...

HQI : 12.82 (-1.00%)
HireQuest Reports Financial Results for the First Quarter 2021

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, today reported financial results for the first quarter ended March 31, 2021.

HQI : 12.82 (-1.00%)
HireQuest Sets First Quarter 2021 Financial Results Conference Call for Monday, May 17, 2021 at 4:30 p.m. ET

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand and temporary staffing services, today announced that it will hold a conference call on Monday, May 17, 2021 at 4:30 p.m. Eastern time...

HQI : 12.82 (-1.00%)
HireQuest Announces Increased Quarterly Cash Dividend of $0.06 Per Share

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, today announced that its Board of Directors has declared an increased quarterly cash dividend...

HQI : 12.82 (-1.00%)
CORRECTING and REPLACING HireQuest Reports Financial Results for the Fourth Quarter and Full-Year 2020

Correcting to add the start of the quote from Rick Hermanns and remove a duplicate quote in the Fourth Quarter 2020 Financial Summary section of the text . Also removing footnote 2 from within the text....

HQI : 12.82 (-1.00%)
HireQuest Reports Financial Results for the Fourth Quarter and Full-Year 2020

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand, temporary, and commercial staffing services, today reported financial results for the fourth quarter and year ended December 31, 2020....

HQI : 12.82 (-1.00%)
HireQuest, Inc. Closes Acquisition of LINK Staffing

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand and temporary staffing services, today announced that its subsidiary, HQ Link Corporation, has closed the acquisition of the franchised...

HQI : 12.82 (-1.00%)
HireQuest Sets Fourth Quarter and Year End 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 4:30 p.m. ET

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand and temporary staffing services, today announced that it will hold a conference call on Thursday, March 25, 2021 at 4:30 p.m. Eastern time...

HQI : 12.82 (-1.00%)
HireQuest, Inc. Closes Acquisition of Snelling Staffing

HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand and temporary staffing services, today announced that its subsidiary, HQ Snelling Corporation, has closed the acquisition of certain assets...

HQI : 12.82 (-1.00%)

Business Summary

DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada....

See More

Key Turning Points

3rd Resistance Point 6.84
2nd Resistance Point 6.63
1st Resistance Point 6.46
Last Price 6.28
1st Support Level 6.08
2nd Support Level 5.87
3rd Support Level 5.70

See More

52-Week High 6.45
Last Price 6.28
Fibonacci 61.8% 4.80
Fibonacci 50% 4.30
Fibonacci 38.2% 3.79
52-Week Low 2.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Optimizing Trade Entries with the Futures Trading Guide